
Purines and Pyrimidine Derivatives
Purines have a bicyclic structure, consisting of a six-membered ring fused to a five-membered ring, both containing nitrogen atoms in key positions. Purine derivatives, such as adenine and guanine, are essential for the formation of DNA and RNA. These compounds have therapeutic applications in cancer and viral disease treatments by inhibiting cell replication. Pyrimidines, on the other hand, have a monocyclic six-membered structure with two nitrogen atoms. Their derivatives, such as cytosine, thymine, and uracil, are also essential components of DNA and RNA and are used in chemotherapy and antiviral treatments.
At CymitQuimica, we offer purine and pyrimidine derivatives for research in molecular biology, genomics, and the development of innovative therapies.
Found 9219 products for "Purines and Pyrimidine Derivatives".
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Pemetrexed Tromethamide (N2-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoyl)-N5-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-L-glutamine)
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C24H30N6O8Color and Shape:Off-White SolidMolecular weight:530.21251Clopidogrel Related Compound C (methyl (-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, hydrogen sulfate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H16ClNO2S·H2SO4Color and Shape:White PowderMolecular weight:321.059032-Oxo R-Clopidogrel (methyl (2R)-2-(2-chlorophenyl)-2-(2-oxo-2,6,7,7a-tetrahydrothieno[3,2-c]pyridin-5(4H)-yl)acetate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H16ClNO3SColor and Shape:White Off-White SolidMolecular weight:337.05394Febuxostat Related Compound E (2-(3-Cyano-4-propoxyphenyl)-4-methylthiazole-5-carboxylic acid)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C15H14N2O3SColor and Shape:White Fine PowderMolecular weight:302.07251Pemetrexed Acid (4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoic acid)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C15H14N4O3Color and Shape:Off-White SolidMolecular weight:298.10659Clopidogrel Amide ((S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C15H15ClN2OSColor and Shape:White Off-White SolidMolecular weight:306.05936Pemetrexed Glutamide Trisodium Salt (((S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-4-carboxybutanoyl)-L-glutamic acid, sodium salt)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C25H28N6O9·3NaColor and Shape:Off-White SolidMolecular weight:556.19178Pemetrexed Disodium Enantiomer ((2R)-2-[[4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid, sodium salt)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C20H19N5O6NaColor and Shape:Pale Green SolidMolecular weight:576.5Pemetrexed Glutamide Sodium ((S)-4-((S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-4-carboxybutanamido)-4-carboxybutanoate, sodium salt)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C25H27N6O9·NaColor and Shape:Blue SolidMolecular weight:555.18395Ergotaminine
CAS:Alkaloids of rye ergot and their derivatives; salts thereof, nesoiFormula:C33H35N5O5Color and Shape:White Off-White Light Grey Crystalline PowderMolecular weight:581.26382Pemetrexed Sodium 5-Methyl Ester ((S)-2-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-5-methoxy-5-oxopentanoic acid, sodium salt)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C21H22N5O6·NaColor and Shape:Pale Yellow SolidMolecular weight:440.15701Ondansetron
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormula:C18H19N3OColor and Shape:White Off-White PowderMolecular weight:293.15281Clopidogrel Ethyl Ester Sulfate (ethyl (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate, sulfate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C17H18ClNO2S·H2O4SColor and Shape:White Off-White SolidMolecular weight:335.07468Clopidogrel Related Compound A ((+)-(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C15H14ClNO2S·HClColor and Shape:Off-White PowderMolecular weight:307.04338Ondansetron Related Compound D (1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormula:C14H13NOColor and Shape:White Off-White PowderMolecular weight:211.09971Allopurinol Related Compound D (Ethyl 5-amino-1H-pyrazole-4-carboxylate)
CAS:Compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure nesoiFormula:C6H9N3O2Color and Shape:White Light Yellow Crystalline PowderMolecular weight:155.06948Clopidogrel Related Compound B (Methyl(+/-)-(o-chlorophenyl)-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-acetate, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H17Cl2NO2SColor and Shape:White Off-White PowderMolecular weight:357.03571Clopidogrel Open Ring Hydrochloride (methyl (S)-2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino) acetate, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C15H16ClNO2S·HClColor and Shape:White Off-White SolidMolecular weight:345.03571Methyl 2-chloro-β-D-phenylalanine (methyl (R)-2-amino-2-(2-chlorophenyl)acetate, hydrochloride)
CAS:Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, nesoiFormula:C9H10ClNO2·HClColor and Shape:White Off-White SolidMolecular weight:235.01668Caffeine Related Compound F (1,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C7H8N4O2Color and Shape:White Fine PowderMolecular weight:180.06473Allopurinol Related Compound B (5-(formylamino)-1H-pyrazole-4-carboxamide)
CAS:Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C5H6N4O2Color and Shape:White PowderMolecular weight:154.04908Pemetrexed Dimethyl Ester (dimethyl (4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoyl)-L-glutamate)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C22H25N5O6Color and Shape:Off-White SolidMolecular weight:455.18048Ondansetron Resolution Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:Off-White White PowderMethylbenzhydrol (2-Methylbenzhydrol)
CAS:Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoiFormula:C14H14OColor and Shape:White PowderMolecular weight:198.10447Aspirin
CAS:Ortho-acetylsalicylic acid (aspirin), its salts and estersFormula:C9H8O4Color and Shape:White Colorless SolidMolecular weight:180.04226Caffeine Related Compound D (3,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione)
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFormula:C7H8N4O2Color and Shape:White Crystalline PowderMolecular weight:180.06473Theophylline
CAS:Theophylline and aminophylline (excluding fenetylline) and their derivatives, salts thereof, not elsewhere specified or includedFormula:C7H8N4O2Color and Shape:White PowderMolecular weight:180.17 g/molFebuxostat Related Compound D (2-[4-(sec-Butoxy)-3-cyanophenyl]-4-methylthiazole-5-carboxylic acid)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C16H16N2O3SColor and Shape:Off-White Fine PowderMolecular weight:316.08816Febuxostat Related Compound C (Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C14H12N2O3SColor and Shape:Off-White Fine PowderMolecular weight:288.05686Orphenadrine Citrate
CAS:Aromatic drugs of amino-alcohols, other than those contg more than one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormula:C18H23NO·C6H8O7Color and Shape:White Crystalline PowderMolecular weight:269.17796Ondansetron Hydrochloride
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C18H19N3O·HCl·2H2OColor and Shape:White Off-White PowderMolecular weight:293.15281Clopidogrel-β-D-glucuronide ((2S,3S,4S,5R,6S)-6-((S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C21H22ClNO8SColor and Shape:White Off-White SolidMolecular weight:483.07547Clopidogrel Thienopyridinium Chloride (5-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)thieno[3,2-c]pyridin-5-ium, chloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H13ClNO2S·ClColor and Shape:Off-White SolidMolecular weight:318.03555Clopidogrel Bisulfate
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H16ClNO2S·H2SO4Color and Shape:White Off-White PowderMolecular weight:321.05903Febuxostat
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C16H16N2O3SColor and Shape:White Off-White PowderMolecular weight:316.08816Imidazole (1H-Imidazole)
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormula:C3H4N2Color and Shape:White Light Yellow Crystalline PowderMolecular weight:68.03745Pemetrexed Sodium 1-Methyl Ester ((S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-5-methoxy-5-oxopentanoic acid, sodium salt)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C21H22N5O6·NaColor and Shape:White Off-White SolidMolecular weight:440.15701Clopidogrel Open Ring R-enantiomer (methyl (R)-2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino) acetate, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C15H16ClNO2S·HClColor and Shape:White Off-White SolidMolecular weight:309.05903Acetaminophen
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C8H9NO2Color and Shape:White PowderMolecular weight:151.06333Ondansetron Related Compound A (3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride)
CAS:Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C16H20N2O·HClColor and Shape:White SolidMolecular weight:256.15756Ondansetron Related Compound C (9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C13H13NOColor and Shape:White Powder ClumpyMolecular weight:199.09971Clopidogrel Acid N-Oxide (5-((S)-carboxy(2-chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-oxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C15H14ClNO3SColor and Shape:White Off-White SolidMolecular weight:323.03829Allopurinol
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C5H4N4OColor and Shape:White PowderMolecular weight:136.03851rac-Clopidogrel Acid N-Oxide (5-(carboxy(2-chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-oxide)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C15H14ClNO3SColor and Shape:White Off-White SolidMolecular weight:323.03829Pemetrexed Acid N-Hydroxysuccinimide Ester (2,5-dioxopyrrolidin-1-yl 4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoate)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C19H17N5O5Color and Shape:White Off-White SolidMolecular weight:395.12297Clopidogrel Diester Enantiomer Sulfate ((S)-1-(2-chlorophenyl)-2-methoxy-2-oxoethyl (R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate, sulfate)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C24H21Cl2NO4S·H2SO4Color and Shape:White Off-White SolidMolecular weight:489.05683Ondansetron Related Compound G (3-[(1H-Imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C17H17N3OColor and Shape:White PowderMolecular weight:279.13716(R)-Clopidogrel Carboxylic Acid ((R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C15H14ClNO2SColor and Shape:Off-White SolidMolecular weight:307.04338Pemetrexed Disodium (Disodium N-{p-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-l-glutamate heptahydrate)
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C20H19N5Na2O6·7H2OColor and Shape:White PowderMolecular weight:597.18702Allopurinol Related Compound E (Ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate)
CAS:Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C7H9N3O3Color and Shape:White Off-White PowderMolecular weight:183.06439

